Alcon AG at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2021 / 12:45PM GMT
Cecilia E. Furlong - Morgan Stanley, Research Division - Equity Analyst

Thank you for joining us for the fourth day of the 2021 Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst and a member of the health care research team here at Morgan Stanley. It's my pleasure to have Alcon with us today, David Endicott, CEO and Director; and Tim Stonesifer, CFO. And before we begin, I'll run through our disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

With that, David, Tim, thank you for joining us today.

David J. Endicott - Alcon Inc. - CEO & Director

Thanks, Cecilia. It's been a pleasure to be here. A couple maybe just introductory remarks, if I may. I think we're really pleased with the quarter. I think it was strong growth, and it was largely driven by

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot